Companies: 11,062     total market cap: C$211.651 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1318
Rank
C$24.05 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
C$239.20
Share price
2.64%
Change (1 day)
39.40%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of March 2026 : C$4.83 Billion

According to Neurocrine Biosciences 's latest financial reports the company has C$4.83 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$C$4.45 B19.88%
2024-12-31$C$3.71 B25.53%
2023-12-31$C$2.96 B27.75%
2022-12-31$C$2.31 B32.34%
2021-12-31$C$1.75 B21.94%
2020-12-31$C$1.43 B72.63%
2019-12-31$C$0.83 B27.02%
2018-12-31$C$0.65 B39.97%
2017-12-31$C$0.46 B10.57%
2016-12-31$C$0.42 B-28.13%
2015-12-31$C$0.58 B143.11%
2014-12-31$C$0.24 B88.95%
2013-12-31$C$0.12 B-16.5%
2012-12-31$C$0.15 B151.18%
2011-12-31$C$61.11 M216.04%
2010-12-31$C$19.33 M364.79%
2009-12-31$C$4.16 M-90.7%
2008-12-31$C$44.71 M-62.24%
2007-12-31$C$0.11 B-67.68%
2006-12-31$C$0.36 B-19.32%
2005-12-31$C$0.45 B-3.98%
2004-12-31$C$0.47 B-6.77%
2003-12-31$C$0.50 B43.25%
2002-12-31$C$0.35 B-28.37%
2001-12-31$C$0.49 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
C$128.31 B 2,553.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-C$9.39 Billion-294.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.28 B 815.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$2.98 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$51.66 Million-101.07%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.79 B-83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$0.56 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
C$14.10 B 191.62%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com